14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of BEAM
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Beam Therapeutics Inc. stock price ended at $21.74 on Wednesday, after gaining 2.45%.
(Updated on May 01, 2024)

Sell candidate since Mar 22, 2024 Loss -35.36% PDF

The Beam Therapeutics Inc. stock price gained 2.45% on the last trading day (Wednesday, 1st May 2024), rising from $21.22 to $21.74. During the last trading day the stock fluctuated 8.66% from a day low at $21.01 to a day high of $22.83. The price has fallen in 6 of the last 10 days and is down by -10.57% for this period. Volume fell on the last day by -130 thousand shares and in total, 1 million shares were bought and sold for approximately $28.46 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -22.20% during the next 3 months and, with a 90% probability hold a price between $11.90 and $28.97 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

BEAM Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Beam Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $22.03 and $28.70. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, February 27, 2024, and so far it has fallen -51.76%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Beam Therapeutics Inc. stock

Beam Therapeutics Inc. finds support from accumulated volume at $21.60 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.82 between high and low, or 8.66%. For the last week, the stock has had daily average volatility of 6.00%.

Beam Therapeutics Inc. is oversold on RSI14 (17). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BEAM) For The Upcoming Trading Day Of Thursday 2nd

For the upcoming trading day on Thursday, 2nd we expect Beam Therapeutics Inc. to open at $21.86, and during the day (based on 14 day Average True Range), to move between $20.22 and $23.26, which gives a possible trading interval of +/-$1.52 (+/-6.97%) up or down from last closing price. If Beam Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 13.94% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $21.60 (0.64%) than the resistance at $23.90 (9.94%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

Beam Therapeutics Inc. will release earnings BMO on Wednesday, May 08, 2024.The consensus among the analysts for the expected earnings (EPS) is -$1.45. We will update the financials statements for Beam Therapeutics Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 8.93% in the first trading day after earnings release.

Is Beam Therapeutics Inc. stock A Buy?

Beam Therapeutics Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.386 Sell Candidate Unchanged

Predicted Opening Price for Beam Therapeutics Inc. of Thursday, May 2, 2024

Fair opening price May 2, 2024 Current price
$21.86 ( 0.552%) $21.74

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for BEAM

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 23.68 8.92 %
R2 22.98 5.73 %
R1 22.56 3.75 %
Current price: 21.74
Support S1 21.16 -2.65 %
S2 20.74 -4.62 %
S3 20.04 -7.82 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 27.06 24.47 %
R2 25.70 18.22 %
R1 23.90 9.94 %
Current price 21.74
Support S1 21.60 -0.644%
S2 21.38 -1.66%
S3 21.22 -2.39%

BEAM Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jan 22, 2014 Feb 04, 2014 Mar 03, 2014 $0.225 0%
2 Sep 19, 2013 Nov 04, 2013 Dec 02, 2013 $0.225 0%
3 Jul 31, 2013 Aug 12, 2013 Sep 03, 2013 $0.225 0%
4 Apr 24, 2013 May 06, 2013 Jun 03, 2013 $0.225 0%
5 Jan 28, 2013 Feb 04, 2013 Mar 01, 2013 $0.225 0%

FAQ

What is the symbol for Beam Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Beam Therapeutics Inc. is BEAM and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Beam Therapeutics Inc. Stock?
Beam Therapeutics Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Beam Therapeutics Inc. Stock?
Beam Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Beam Therapeutics Inc. Stock.

What's the current price of Beam Therapeutics Inc. Stock?
As of the end of day on the May 01, 2024, the price of an Beam Therapeutics Inc. (BEAM) share was $21.74.

What is the 52-week high and low for Beam Therapeutics Inc. Stock?
The 52-week high for Beam Therapeutics Inc. Stock is $49.50 and the 52-week low is $16.95.

What is the market capitalization of Beam Therapeutics Inc. Stock?
As of the May 01, 2024, the market capitalization of Beam Therapeutics Inc. is 1.775B.

When is the next earnings date for Beam Therapeutics Inc.?
The upcoming earnings date for Beam Therapeutics Inc. is May 08, 2024.
Click to get the best stock tips daily for free!

About Beam Therapeutics Inc.

Beam Therapeutics. Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia; and BEAM-... BEAM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT